European Commission has approved a combination of the drugs Opdivo and Yervoy to treat adult patients with colorectal cancer. Patients in the European Union with this tumor will now have access to dual immunotherapy treatment. Opdivo and Yervoy are currently approved in the EU for five different types of cancer.